To help illuminate the impact of this rapid expansion, PANTHERx released new findings capturing the real-world experience across rare disease patients, prescribers, and payers supported by a dozen ...
The experimental IPF therapy deupirfenidone was granted orphan drug designation by regulatory agencies in the U.S. and the European Union.
FDA PDUFA Goal Date Set for October 17, 2026 PITTSBURGH, Feb. 25, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that ...
The opioid epidemic hit southwestern Pennsylvania hard, with fatal overdoses claiming an average of two lives daily in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results